Skip to the page

Data / Drug companies / Carnitine Analog

Carnitine Analog drugs: 2 drugs from 18 companies in the FDA NDC directory

Carnitine Analog is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 29 products in this class from 18 companies, covering 2 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on September 30, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 18Companies
  • 29Products
  • 2Drugs by generic name

Drugs in the Carnitine Analog class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Levocarnitine1610
Levocarnitine oral11

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Leadiant Biosciences, Inc.4solution; injection, solutionNew drug applications (NDA)December 16, 1992
Ani Pharmaceuticals, Inc.3solution; tabletGeneric drugs (ANDA)December 9, 2022
Energique, Inc.3liquidUnapproved homeopathic productsJanuary 28, 2025
Professional Complementary Health Formulas3liquidUnapproved homeopathic productsAugust 15, 1984
American Regent, Inc.2injection, solutionGeneric drugs (ANDA)June 21, 2023
BioActive Nutritional, Inc.2liquidUnapproved homeopathic productsJanuary 3, 2025
Baxter Healthcare Corporation1injection, solutionGeneric drugs (ANDA)July 2, 2026
Deseret Biologicals, Inc.1liquidUnapproved homeopathic productsOctober 10, 2023
Devatis, Inc.1injection, solutionGeneric drugs (ANDA)November 1, 2025
Gland Pharma Limited1injection, solutionGeneric drugs (ANDA)September 30, 2026
Guna Spa1solution/ dropsUnapproved homeopathic productsMay 27, 2010
Hikma Pharmaceuticals USA Inc.1injectionGeneric drugs (ANDA)June 1, 2023
Liddell Laboratories, Inc.1sprayUnapproved homeopathic productsJuly 26, 2021
Nutritional Specialties, Inc.1sprayUnapproved homeopathic productsJuly 7, 2023
Rising Pharma Holdings, Inc.1tabletGeneric drugs (ANDA)December 1, 2020
Rising Pharma Holdings, Inc.1solutionGeneric drugs (ANDA)September 20, 2004
Saptalis Pharmaceuticals, LLC.1solutionGeneric drugs (ANDA)February 21, 2024
TruPharma, LLC1solutionGeneric drugs (ANDA)February 9, 2022

Dosage forms

Dosage formProductsShare
Liquid931%
Solution724.1%
Injection, solution620.7%
Tablet310.3%
Spray26.9%
Solution/ drops13.4%
Injection13.4%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.